1. OFATUMUMAB WITH IVAC FOR DLBCL PATIENTS WHO FAILED R‐CHOP AND WERE NOT CANDIDATES FOR HIGH‐DOSE THERAPY AND ASCT ‐ PHASE 2 TRIAL OF THE POLISH LYMPHOMA RESEARCH GROUP (PLRG‐8). (12th June 2019) Authors: Paszkiewicz‐Kozik, E.; Michalski, W.; Taszner, M.; Knopińska‐Posłuszny, W.; Mordak‐Domagała, M.; Najda, J.; Borawska, A.; Romejko‐Jarosińska, J.; Chełstowska, M.; Świerkowska, M.; Dąbrowska‐Iwanicka, A.; Malenda, A.; Druzd‐Sitek, A.; Konecki, R.; Kuniega, B.; Osowiecki, M.; Ostrowska, B.; Szpila,... Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗